fda safety communication semaglutide naion 2025 The US Food and Drug Administration has issued a warning letter to Novo Nordisk over alleged lapses in reporting adverse events linked to its blockbuster GLP-1 drugs Ozempic & Wegovy., A study Rybelsus Lawsuit Update May 2026

L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction

Lets explore the myriad of advantages offered by this innovative approach, revealing how its tailored to support your bodys journey toward optimal well-being

Your doctor might suggest you switch to Zepbound in case of prolonged side effects, as some people may have better tolerance to this drug than Ozempic

The safety of TRESIBA in subjects with type 1 diabetes or type 2 diabetes was evaluated in nine trials of 6 12 month duration in adults and in one trial of 12 month duration in pediatric patients 1 year of age and older with type 1 diabetes